一些道德家建议说，组织捐赠者应保留这样的权利，即能够分享诱导多能干细胞系作为疾病模型，药物测试平台以及治疗方案所带来的潜在的巨大商业利益。
Some ethicists suggest that tissue donors deserve a share of the tremendous commercial potential of iPS cell lines as disease models, drug-testing platforms or treatments.
替代性多能干细胞疗法促进法案(StemCell Research Enhancement Act)，该法案鼓励研究通过“目前已知不会伤害胚胎”的方式导出干细胞系。
The Alternative Pluripotent stem cell Therapies Enhancement Act, which promotes research into deriving stem cell lines by methods "that do not knowingly harm embryos."
替代性多能干细胞疗法促进法案(StemCell Research Enhancement Act)，该法案鼓励研究通过“目前已知不会伤害胚胎”的方式导出干细胞系。
The Alternative Pluripotent stem cell Therapies Enhancement Act, which promotes research into deriving stem cell lines by methods "that do not knowingly harm embryos."
应用推荐